BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Domain Therapeutics 



Strasbourg      France
Phone: n/a Fax: n/a


SEARCH JOBS










 Company News
Domain Therapeutics Appoints Dr Youssef L. Bennani As Chairman Of The Board 5/27/2014 11:30:17 AM
Domain Therapeutics Continues Program To Alter Course Of Parkinson's Disease With Renewed Support By The Michael J. Fox Foundation 4/14/2014 8:34:04 AM
Domain Therapeutics Enters Into Collaboration With XOMA Corporation (XOMA) 2/4/2014 9:28:32 AM
Domain Therapeutics Opens A North American Subsidiary At Montreal's NEOMED Institute 1/20/2014 9:02:19 AM
Domain Therapeutics, Université de Montréal And McGill University Sign New Licensing And Partnership Agreement On G-Protein Coupled Receptor Biosensor Technology 12/18/2013 9:26:38 AM
Domain Therapeutics Grants Prexton Therapeutics an Exclusive Option to License and Develop mGluR4 PAMs for Parkinson's Disease 1/22/2013 11:20:58 AM
Domain Therapeutics Enters Into Collaboration Agreement With Ono Pharmaceutical Company, Ltd. in the Field of GPCR-Based Drug Discovery 10/23/2012 9:47:01 AM
Domain Therapeutics Closes EUR Two Million Funding Round 7/17/2012 12:08:56 PM
Domain Therapeutics Wins EUR 933,000 Grant for Schizophrenia Project 3/13/2012 9:27:59 AM
Domain Therapeutics Awarded Grant from The Michael J. Fox Foundation for the Development of Novel mGluR3 PAM Compounds to Treat Parkinson's Disease 1/30/2012 11:32:55 AM
12